AxoGen, Inc. (AXGN) financial statements (2020 and earlier)

Company profile

Business Address 13631 PROGRESS BLVD.
ALACHUA, FL 32615
State of Incorp. MN
Fiscal Year End December 31
SIC 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments100117373026820
Cash and cash equivalents2524373026820
Short-term investments7692     
Receivables1615118532
Inventory, net of allowances, customer advances and progress billings141275433
Inventory141275433
Prepaid expense1      
Other undisclosed current assets7711000
Total current assets:1371515644351426
Noncurrent Assets
Finance lease, right-of-use asset0
Operating lease, right-of-use asset4
Property, plant and equipment12821110
Intangible assets, net (including goodwill)1111111
Intangible assets, net (excluding goodwill)1111111
Deferred costs    111
Total noncurrent assets:17932222
TOTAL ASSETS:1541605946381628
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:151397422
Accounts payable453421 
Accrued liabilities322 0  
Employee-related liabilities86432 0
Other undisclosed accounts payable and accrued liabilities     12
Deferred revenue0
Debt2010   
Deferred revenue and credits00000
Contract with customer, liability0
Other undisclosed current liabilities  44   
Total current liabilities:17131411422
Noncurrent Liabilities
Long-term debt and lease obligation202020262525
Long-term debt, excluding current maturities202020262525
Liabilities, other than long-term debt0000000
Deferred revenue and credits00000
Deferred revenue0
Contract with customer, liability0
Other liabilities 0     
Total noncurrent liabilities:202020262525
Total liabilities:19133431292828
Stockholders' equity
Stockholders' equity attributable to parent13514725158(11)0
Common stock0000000
Additional paid in capital3082971531321117972
Accumulated deficit(173)(151)(128)(118)(103)(90)(72)
Total stockholders' equity:13514725158(11)0
TOTAL LIABILITIES AND EQUITY:1541605946381628

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues102846041271711
Cost of revenue
(Cost of Goods and Services Sold)
(16)(13)(9)(6)(5)(3)(2)
Gross profit:8671513522139
Operating expenses(116)(92)(59)(43)(32)(23)(18)
Other undisclosed operating income     00
Operating loss:(30)(21)(8)(8)(9)(10)(10)
Nonoperating income (expense)3(2)(2)(6)(4)(8)(5)
Investment income, nonoperating32     
Interest and debt expense(2)(2)(2)(5)(4)(7)(5)
Loss from continuing operations before equity method investments, income taxes:(29)(25)(13)(20)(17)(25)(19)
Other undisclosed income from continuing operations before income taxes      5
Net loss:(29)(25)(13)(20)(17)(25)(15)
Other undisclosed net income attributable to parent222547 
Net loss available to common stockholders, diluted:(27)(22)(10)(14)(13)(18)(15)

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(29)(25)(13)(20)(17)(25)(15)
Comprehensive loss, net of tax, attributable to parent:(29)(25)(13)(20)(17)(25)(15)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: